Search results for: “IPO subscription trends”
-
IPO INVESTING in 2025: Oversubscription Trends and Investor Lessons
If you’ve been tracking the stock market this week, you’d know one thing for sure—IPO fever is back in India. Three companies—Urban Company, Shringar House of Mangalsutra, and Dev Accelerator—wrapped up their IPO bidding on Friday, September 12, and the response has been nothing short of spectacular. Retail investors, high-net-worth individuals, and institutional players all…
-
Canara Robeco Share Price Lists At Small Premium Over IPO: What It Means For Investors
Canara Robeco Asset Management Co. lists on the stock market with a small premium over the IPO price. What does this mean for investors and how can you make the most of this opportunity?
-
Midwest IPO: Grey Market Premium, Price Band, and Key Details for Investors
Get the latest updates on the Midwest IPO, including grey market premium, price band, and key details for investors looking to subscribe to this initial public offering.
-
LG Electronics India IPO Listing Date, GMP, and Latest Updates
Get the latest updates on the LG Electronics India IPO, including its listing date, grey market premium, and other key details for Indian investors.
-
Canara HSBC Life Insurance IPO: Latest Updates on Subscription, GMP, and Listing Details
Get the latest updates on the Canara HSBC Life Insurance IPO, including subscription status, grey market premium, and expected listing price. Find out how to invest in this IPO and what it means for Indian investors.
-
WeWork India IPO: Subscription Status, GMP, and Other Key Details
WeWork India Management Ltd’s initial public offering was bid 13% on its second day of subscription. Get the latest updates on the IPO subscription status, GMP, and other key details.
-
IPO GMP Today: WeWork India, Tata Capital, and LG Electronics India – Latest Updates and Analysis
Get the latest updates on the IPOs of WeWork India, Tata Capital, and LG Electronics India, including their grey market premium (GMP) and potential listing gains. Learn how to make informed investment decisions with our expert analysis.
-
Fabtech Technologies IPO Listing: A Muted Debut for the Biopharma Engineering Company
Fabtech Technologies Ltd. made a muted debut on the stock market, listing nearly the same to the IPO price. Get the latest updates on the company’s performance and its implications for Indian investors.
-
Glottis Shares Debut at 35% Discount to IPO Price: What Indian Investors Should Know
Glottis Ltd. made a disappointing debut on the stock market, listing at a 35% discount to its IPO price. What does this mean for Indian investors and the logistics sector?
-
Advance Agrolife IPO Sees 1.87 Times Subscription on Day 2: What Indian Investors Need to Know
The Advance Agrolife IPO has garnered significant interest, with 1.87 times subscription on the second day. Here’s what Indian investors should consider before investing in this agrochemical firm’s public offering.
-
Commtel Networks IPO: Rs 900 Crore Fundraising Plans Through Fresh Issue and OFSCommtel Networks
Commtel Networks has filed its draft red herring prospectus with SEBI to raise Rs 900 crore via an initial public offering, comprising a fresh issue and an offer for sale.
-
Jinkushal Industries IPO Listing Today: Check Latest GMP, Expected Listing Price, and More
Jinkushal Industries Ltd. is set to list on the BSE and NSE today. Check the latest grey market premium, expected listing price, and other key details.
-
TruAlt Bioenergy Share Price Soars On Debut, Lists At 11% Premium Over IPO Price
TruAlt Bioenergy Ltd. made a strong debut on the stock market, listing at a premium of nearly 11% over its IPO price. Get the latest updates on the company’s performance and future plans.
-
WeWork India IPO: Check GMP, Subscription, and Other Details
WeWork India Management Ltd.’s initial public offering has opened for investors to bid, aiming to raise Rs 3,000 crore through the sale of equity. Get the latest updates on the IPO, including GMP, subscription, and other details.
-
Rubicon Research IPO: A Game-Changer for Indian Pharmaceutical Industry
Rubicon Research Ltd., backed by US private equity giant General Atlantic, is set to launch its Rs 1,377.5-crore initial public offering of shares. Here’s what you need to know about this highly anticipated IPO.